Assessing AbbVie (ABBV) Valuation After New Dermatology Data And FDA Label Update [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
AbbVie (ABBV) is back in focus after presenting a broad slate of dermatology data at the 2026 American Academy of Dermatology meeting, including long term results for Skyrizi and Rinvoq, as well as a new FDA label update. See our latest analysis for AbbVie. At a share price of US$214.98, AbbVie has seen a 3.76% 7 day share price return, a 30 day share price return of 8.23% and a year to date share price return of 6.25%, while longer term total shareholder returns of 8.29% over 1 year and 147.42% over 5 years point to momentum that has been built over time as the market weighs fresh dermatology data, upcoming earnings and ongoing governance debates. If advances in immune mediated skin treatments interest you, it can be useful to widen the lens and look at other healthcare names using a focused screener such as 33 healthcare AI stocks With AbbVie trading at US$214.98 and reportedly sitting at a 42% discount to one intrinsic value estimate and a 16% discount to the current analy
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting® [Yahoo! Finance]Yahoo! Finance
- TippingPoint Biosciences Raises $4.5M Seed to Drug Hidden Epigenetic Targets in Deadly Pediatric Brain Cancer [Yahoo! Finance]Yahoo! Finance
- Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting®PR Newswire
- AbbVie to Host First-Quarter 2026 Earnings Conference CallPR Newswire
- 3 Asian Growth Companies With High Insider Ownership Growing Revenues Up To 24% [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 2/4/26 - Miss
ABBV
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/23/26 - Form ARS
- 3/23/26 - Form DEFA14A
- ABBV's page on the SEC website